Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit anti-AHCY Polyclonal Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human AHCY |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-TUBB(beta Tubulin) antibody, Loading control
| Applications | WB |
| Reactivities | Human, Mouse, Chicken, Xenopus, Porcine, Zebrafish, Hamster, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human beta tubulin (within residues 1-100). Swiss-Prot P07437. |
Rabbit polyclonal IRS-1 (Ab-312) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 312 (A-T-SP-P-A). |
Rabbit Anti-NMDA NR2B Subunit Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein from the C-terminal region of the NR2B subunit |
Rabbit Anti-NMDA NR2B Subunit (Tyr1472) Antibody (Phospho-Specific)
| Applications | WB |
| Reactivities | Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic phospho-peptide corresponding to amino acid residues surrounding Tyr1472 conjugated to KLH |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-NOTCH2 (Cleaved-Ala1734) Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-NOTCH2 (Cleaved-Ala1734) Antibody: A synthesized peptide derived from human NOTCH2 (Cleaved-Ala1734) |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit polyclonal eNOS (Thr495) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human eNOS around the phosphorylation site of threonine 495 (K-K-TP-F-K). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit polyclonal antibody to BLU (zinc finger, MYND-type containing 10)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 377 and 440 of BLU (Uniprot ID#O75800) |
Rabbit Polyclonal antibody to RAC1 (ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1))
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 1 and 196 of RAC1 (Uniprot ID#P63000 isoform B) |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Anti-RAC2 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 50-192 amino acids of human ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Rabbit Polyclonal CrkII (Tyr221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CrkII around the phosphorylation site of Tyrosine 221 |
| Modifications | Phospho-specific |
Rabbit polyclonal GRB2 (Ab-159) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GRB2 around the phosphorylation site of serine 159 (K-S-SP-A-P). |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Active filters
Category
- Antibodies
Reactivities
- Rat
Applications
- WB
Antibody Hosts
- Rabbit
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Citations
- Yes
Availabilities
- In Stock
Filter by
Target Symbol
- BAX (2)
- GAPDH (2)
- GRIN2B (2)
- IRS1 (2)
- RAC1 (2)
- STAT5A (2)
- ABCD2 (1)
- ACTB (1)
- ACTG2 (1)
- AHCY (1)
- ANTXR1 (1)
- AOX1 (1)
- BAG3 (1)
- BID (1)
- BRAF (1)
- CCNA2 (1)
- CCNE1 (1)
- CD44 (1)
- CDK6 (1)
- CDKN1A (1)
- CHMP4C (1)
- COL2A1 (1)
- CRK (1)
- CSTB (1)
- CTNNB1 (1)
- CUX1 (1)
- CYP19A1 (1)
- CYP3A4 (1)
- DDX58 (1)
- DIABLO (1)
- ENO2 (1)
- EXT1 (1)
- FZD2 (1)
- GAB2 (1)
- GAD1 (1)
- GPD2 (1)
- GREM1 (1)
- HAP1 (1)
- HOXC8 (1)
- HSP90AA1 (1)
- IGF2BP3 (1)
- IL1R1 (1)
- IRF3 (1)
- ITGA4 (1)
- JAK1 (1)
- JAK2 (1)
- KDR (1)
- KLK5 (1)
- LIMK1 (1)
- MAP3K5 (1)
- MAPK3 (1)
- MMP2 (1)
- MSH6 (1)
- MYCN (1)
- NEUROD1 (1)
- NOS3 (1)
- NOTCH2 (1)
- NPHS2 (1)
- NR3C1 (1)
- NR4A3 (1)
- NTRK2 (1)
- OAT (1)
- PAK1 (1)
- PAK2 (1)
- PAK5 (1)
- PFKFB2 (1)
- PLK3 (1)
- POU5F1 (1)
- PPARGC1A (1)
- PRKAR1A (1)
- RAC2 (1)
- RELA (1)
- RHBDD2 (1)
- ROCK1 (1)
- SCARB1 (1)
- SCNN1B (1)
- SDC4 (1)
- SLC18A2 (1)
- SLC2A1 (1)
- SLC44A1 (1)
- SNAP23 (1)
- SOX2 (1)
- SPP1 (1)
- ST6GAL1 (1)
- STAT3 (1)
- STMN1 (1)
- TNFRSF10D (1)
- TP53INP1 (1)
- TPM2 (1)
- TRAF3IP1 (1)
- TUBB (1)
- TUBB3 (1)
- ZMYND10 (1)
Knockout (KO) Validation
Modifications
Families
- Druggable Genome (72)
- Transmembrane (25)
- Transcription Factors (18)
- ES Cell Differentiation/IPS (16)
- Protein Kinase (14)
- Stem cell - Pluripotency (5)
- Adult stem cells (4)
- Embryonic stem cells (4)
- Secreted Protein (4)
- Stem cell relevant signaling - DSL/Notch pathway (4)
- Cancer stem cells (3)
- Induced pluripotent stem cells (2)
- Nuclear Hormone Receptor (2)
- P450 (2)
- Protease (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- GPCR (1)
- Ion Channels: Glutamate Receptors (1)
Pathways
- Pathways in cancer (24)
- Focal adhesion (16)
- MAPK signaling pathway (13)
- Regulation of actin cytoskeleton (13)
- Metabolic pathways (12)
- Neurotrophin signaling pathway (12)
- Chemokine signaling pathway (11)
- Colorectal cancer (10)
- Axon guidance (9)
- Chronic myeloid leukemia (9)
- ErbB signaling pathway (9)
- Pancreatic cancer (9)
- Renal cell carcinoma (9)
- Amyotrophic lateral sclerosis (ALS) (8)
- Fc gamma R-mediated phagocytosis (8)
- Leukocyte transendothelial migration (8)
- Natural killer cell mediated cytotoxicity (8)
- Adipocytokine signaling pathway (7)
- Apoptosis (7)
- Insulin signaling pathway (7)
- Prostate cancer (7)
- Acute myeloid leukemia (6)
- Adherens junction (6)
- Alzheimer's disease (6)
- Toll-like receptor signaling pathway (6)
- VEGF signaling pathway (6)
- Wnt signaling pathway (6)
- p53 signaling pathway (6)
- B cell receptor signaling pathway (5)
- ECM-receptor interaction (5)
- Fc epsilon RI signaling pathway (5)
- Huntington's disease (5)
- Jak-STAT signaling pathway (5)
- Pathogenic Escherichia coli infection (5)
- T cell receptor signaling pathway (5)
- Viral myocarditis (5)
- Bladder cancer (4)
- Cell cycle (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- Glioma (4)
- Melanoma (4)
- Progesterone-mediated oocyte maturation (4)
- Small cell lung cancer (4)
- Vascular smooth muscle contraction (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (3)
- Cytokine-cytokine receptor interaction (3)
- Cytosolic DNA-sensing pathway (3)
- Dilated cardiomyopathy (3)
- Endometrial cancer (3)
- Gap junction (3)
- Glycolysis / Gluconeogenesis (3)
- Hematopoietic cell lineage (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Long-term depression (3)
- Long-term potentiation (3)
- Melanogenesis (3)
- NOD-like receptor signaling pathway (3)
- Non-small cell lung cancer (3)
- Prion diseases (3)
- RIG-I-like receptor signaling pathway (3)
- Thyroid cancer (3)
- Type II diabetes mellitus (3)
- Arginine and proline metabolism (2)
- Basal cell carcinoma (2)
- Cell adhesion molecules (CAMs) (2)
- Dorso-ventral axis formation (2)
- Drug metabolism - cytochrome P450 (2)
- Endocytosis (2)
- GnRH signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- Oocyte meiosis (2)
- TGF-beta signaling pathway (2)
- Tight junction (2)
- mTOR signaling pathway (2)
- ABC transporters (1)
- Alanine (1)
- Androgen and estrogen metabolism (1)
- Antigen processing and presentation (1)
- Butanoate metabolism (1)
- Calcium signaling pathway (1)
- Cardiac muscle contraction (1)
- Cysteine and methionine metabolism (1)
- Drug metabolism - other enzymes (1)
- Fructose and mannose metabolism (1)
- Glycerophospholipid metabolism (1)
- Heparan sulfate biosynthesis (1)
- Linoleic acid metabolism (1)
- Maturity onset diabetes of the young (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Mismatch repair (1)
- N-Glycan biosynthesis (1)
- Nicotinate and nicotinamide metabolism (1)
- Notch signaling pathway (1)
- Parkinson's disease (1)
- RNA degradation (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Selenoamino acid metabolism (1)
- Systemic lupus erythematosus (1)
- Taurine and hypotaurine metabolism (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- Tyrosine metabolism (1)
- Valine (1)
- Vibrio cholerae infection (1)
- Vitamin B6 metabolism (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)
- leucine and isoleucine degradation (1)